Early-Onset Effluvium Secondary to COVID-19: Clinical and Histologic Characterization

    December 2021 in “ Journal of The American Academy of Dermatology ”
    Anna Carolina Miola, Lívia Caramaschi Florêncio, Maria Estela Bellini Ribeiro … Hélio Amante Miot
    Studysummary This article discusses early-onset telogen effluvium following COVID-19 infection and reports no new results, encouraging further exploration into its pathogenesis and differences compared to other acute forms.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Research cited in this study 6

    1. Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management JAAD International · 2021
    2. Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium Journal of The American Academy of Dermatology · 2021
    3. SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study Journal of the European Academy of Dermatology and Venereology · 2020
    4. Telogen Effluvium: A Comprehensive Review Clinical, Cosmetic and Investigational Dermatology · 2019
    5. Telogen Effluvium: New Concepts and Review Archives of Dermatology · 1993
    6. Telogen Effluvium: A Comprehensive Review Archives of Dermatology · 1993